<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>One hundred eighty-eight unselected consecutive patients with "de novo" <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) were studied cytogenetically </plain></SENT>
<SENT sid="1" pm="."><plain>They were subclassified as 4 <z:hpo ids='HP_0004828'>refractory anemia with ringed sideroblasts</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>), 67 <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA), 58 <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>), 40 RAEB in transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t), and 19 <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>The overall incidence of chromosome abnormalities was 69% </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t patients showed karyotypic changes, more often than RA and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> (76% and 100% vs. 56% and 42%, respectively) </plain></SENT>
<SENT sid="4" pm="."><plain>The most frequent single anomaly was del(5)(q13-q22q33) (22 cases), followed by <z:mp ids='MP_0004026'>monosomy</z:mp> 7 or del 7q (11 cases), del(11) (q14q23) (8 cases), <z:mp ids='MP_0004027'>trisomy</z:mp> 8 (4 cases) </plain></SENT>
<SENT sid="5" pm="."><plain>Complex karyotypes (defined by the presence of three or more structural or numerical abnormalities) were detected in 33 patients </plain></SENT>
<SENT sid="6" pm="."><plain>With regard to the FAB classification, del (5)(q13q33) was associated with RA, and complex rearrangements with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t </plain></SENT>
<SENT sid="7" pm="."><plain>Leukemic transformation occurred in 66 patients (46%), none with a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype or del(11)(q14q23) as single abnormality </plain></SENT>
<SENT sid="8" pm="."><plain>In patients carrying 5q- alone, <z:hpo ids='HP_0011009'>acute</z:hpo> evolution correlated with proximal breakpoint localization, being found in no case with del(5)(q13q33) but in three out of four cases with del(5)(q22q33) </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0002488'>Acute leukemia</z:hpo> (AL) progression happened in <z:hpo ids='HP_0000001'>all</z:hpo> cases with complex rearrangements and <z:mp ids='MP_0004026'>monosomy</z:mp> 7 or del(7q) </plain></SENT>
<SENT sid="10" pm="."><plain>Two of the four <z:mp ids='MP_0004027'>trisomy</z:mp> eight patients evolved in AL </plain></SENT>
<SENT sid="11" pm="."><plain>By using the Cox proportional hazard regression analysis it was demonstrated that the karyotype abnormality was a significant predictor of leukemic transformation (P &lt; 0.001) </plain></SENT>
<SENT sid="12" pm="."><plain>Patients with abnormal karyotypes without complex abnormalities had a survival (median survival 12 months) shorter than that of cases with only <z:mpath ids='MPATH_458'>normal</z:mpath> metaphases (median 83 months) (P &lt; 0.001); patients with a mixture of <z:mpath ids='MPATH_458'>normal</z:mpath>/abnormal metaphases had a median survival of 31 months </plain></SENT>
<SENT sid="13" pm="."><plain>The median survival for complex karyotypes was 7 months </plain></SENT>
<SENT sid="14" pm="."><plain>Among cases with single defects, del(5)(q13q33) showed the best survival (64 months), <z:mp ids='MP_0004026'>monosomy</z:mp> 7 and del(7q) the worst (7 months) (P &lt; 0.001) </plain></SENT>
</text></document>